Scitara signs deal with PerkinElmer on IT platform

By The Science Advisory Board staff writers

April 25, 2022 -- Scitara is partnering with PerkinElmer on a new scientific integration platform that will grant scientists access to cross-functional data.

The Scitara Scientific Integration Platform will support PerkinElmer's Signals Research Suite informatics platform, which provides end-to-end scientific data and workflow management, with laboratory instruments, applications, and resources. Scitara's technology uses cloud-native infrastructure and will result in a fully connected laboratory with standard data integrity, data mobility, system flexibility, and user reconfigurability, the firm said.

Scientists will be able to extract the maximum value from legacy equipment and introduce new technology into the lab that will improve productivity, such as artificial intelligence (AI) and automation tools, Scitara added.

PerkinElmer expands in vivo imaging portfolio
PerkinElmer announced it is expanding its in vivo imaging portfolio with the launch of the Vega imaging system. The company said it will demonstrate Vega...
11 new developments in cell and gene therapy
There have been a number of recent developments in the cell and gene therapy field. Bruce Carlson, publisher of Cell and Gene Therapy Business Outlook,...
PerkinElmer introduces new ChemDraw v.21 software
PerkinElmer has launched ChemDraw v.21 software for the import, animation, creation and sharing of 3D chemical structures intrinsically in the Microsoft...
Scitara raises $15M to disrupt lab data integration market
Scitara has closed a series B financing round with an additional investment of $15 million. The funding will aid Scitara's growth plans to solve...
IDBS and Scitara form strategic partnership
Biopharmaceutical lifecycle management technology provider IDBS and Scitara have inked a strategic partnership agreement.
Scitara raises $5M to develop its DLX platform
Scitara has raised $5 million in series A financing that it plans to use to fully develop its Digital Lab Exchange (DLX) platform.

Copyright © 2022

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter